This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Numab Therapeutics Ag. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Teddy Beltrametti: Innovator in Antibody Development
Introduction
Teddy Beltrametti is a notable inventor based in Schattdorf, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on innovative solutions that have the potential to impact medical treatments.
Latest Patents
Teddy holds a patent for Anti-CD3 antibodies. This invention relates to novel antibodies that are specific for human CD3, particularly for the CD3ε domain. His patent represents a significant advancement in the understanding and application of antibodies in therapeutic contexts.
Career Highlights
Teddy is currently associated with Numab Therapeutics AG, a company known for its cutting-edge research in antibody development. His role at Numab Therapeutics AG allows him to collaborate with other experts in the field and contribute to groundbreaking innovations.
Collaborations
Teddy has worked alongside talented colleagues such as Tea Gunde and Christian Hess. Their combined expertise fosters a collaborative environment that enhances the potential for innovative breakthroughs in biotechnology.
Conclusion
Teddy Beltrametti's work in the field of antibody development exemplifies the spirit of innovation in biotechnology. His contributions, particularly through his patent on Anti-CD3 antibodies, highlight the importance of research and collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile